Categories AlphaGraphs, Earnings, Finance

Strong loan growth drives NII for US Bancorp in Q2

US Bancorp (NYSE: USB) reported second-quarter earnings results that surpassed Wall Street estimates, despite headwinds associated with a low-interest-rate environment.

Total net revenue of $5.82 billion was up 3.2% compared to the same period last year, helped by strong growth in payments services, wealth management, and commercial products. The top line surpassed analysts’ estimates of $5.73 billion.

Strong loan growth drives NII for US Bancorp in Q2

Net income grew 7% to 1.09 per share, beating the Street consensus by 2 cents. The increase in net income was driven revenue growth during the quarter, but was partially offset by noninterest expense growth of 2.2%.

Strong loan and deposit growth during the quarter, which benefited from heightened consumer confidence, drove Net Interest Income (NII) in Q2. NII improved 3.4% to $3.33 billion, as average total loans grew 3.8% year-over-year.  

READ: JPMorgan Chase beats in Q2 on tax benefit

Total commercial loans grew 5%, residential mortgages jumped 9.9%, credit card loans improved 7.6%, and total other retail loans edged up 2.7% in Q2.

“We delivered strong results this quarter and we feel good about underlying momentum heading into the second half of the year. In the second quarter, we delivered a return on tangible common equity of 19.2% and returned 79% of our earnings through dividends and share buybacks, said CEO Andy Cecere.  

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top